Adriana Paula da Silva

Adriana Paula da Silva

Auto-generated profile, based on publicly available information

Adriana Paula da Silva

Universidade Federal do Triângulo Mineiro, Brazil

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Clinics
Verified
Journal Article
Open access
FRFlávia Alves Ribeiro
Flávia Alves Ribeiro
ERElisabete Aparecida Mantovani Rodrigues de Resende
Elisabete Aparecida Mantovani Rodrigues de Resende
ASAdriana Paula da Silva
Adriana Paula da Silva
JTJanaíne Machado Tomé
Janaíne Machado Tomé
HPHeloísa Marcelina da Cunha Palhares
Heloísa Marcelina da Cunha Palhares
MBMaria de Fátima Borges
Maria de Fátima Borges
Follow-up studies of girls with premature adrenarche have reported the development of polycystic ovary syndrome, insulin resistance, and dyslipidemia and a propensity to cardiovascular disease. The aim of this study was to analyze the presence of these conditions in patients previously treated at the Universidade Federal do Triângulo Mineiro. A total of 130 medical records reported premature adrenarche. One hundred and twenty-two patients were invited to participate, of whom 54 accepted; 34 patients were selected, as they had reached their final height. Anthropometric, blood glucose, insulin, and lipid and hormonal profile (LH, FSH, estradiol, 17α-OH-progesterone, androstenedione, dehydroepiandrosterone sulfate, testosterone) data were obtained, the HOMA-IR index was calculated, and pelvic ultrasonography was performed. To characterize polycystic ovary syndrome and metabolic syndrome, the Rotterdam and International Diabetes Federation criteria, respectively, were used. Data were analyzed according to measures of dispersion, frequency and correlations of interest. The age of the participants ranged from 15.2 to 28.2 years/months; 23.5% of the patients were overweight, 11.8% were obese, 29.4% had a large waist circumference, and 8.8% were hypertensive. None of the patients had altered glucose levels, and insulin levels and HOMA-IR were elevated in 29.4% and 38.2% of the participants, respectively; 14.7% of the patients exhibited acanthosis nigricans. The lipid profiles of the participants were variable, and one patient (2.9%) had metabolic syndrome. Polycystic ovary syndrome was found in 41.2% of patients. The percentage of patients with polycystic ovary syndrome who also had overweight, obesity and insulin resistance corroborates the literature data about the need for follow-up aiming at interventions, especially for conditions associated with cardiometabolic risk.

1 April 2021 in Radiologia Brasileira
Verified
Journal Article
Open access
PDF file
LSLuís Ronan Marquez Ferreira de Souza
Luís Ronan Marquez Ferreira de Souza
NSNathalie de Almeida Sedassari
Nathalie de Almeida Sedassari
EDEduarda Lemes Dias
Eduarda Lemes Dias
FDFernanda Cristina Mattos Dib
Fernanda Cristina Mattos Dib
HPHeloisa Marcelina Cunha Palhares
Heloisa Marcelina Cunha Palhares
MBMaria de Fátima Borges
Maria de Fátima Borges
Objective: To establish ultrasound reference values for thyroid volumes in children up to 3 years of age, given that ultrasound of the thyroid is an essential examination in the diagnosis of childhood thyroid disease. Materials and Methods: This was a prospective study conducted in an iodine-sufficient city in southeastern Brazil. A total of 100 healthy children underwent clinical evaluation, anthropometric examination, and cervical ultrasound in accordance with conventional protocols. We evaluated characteristics such as echotexture, thyroid lobe volume, and total thyroid volume. The children were divided into five groups, by age: < 2 months; 2-12 months; 12-18 months; 18-24 months; and 24-36 months. Results: The mean thyroid volume was lower in the < 2 month age group than in the other groups (0.4 mL vs. 0.18-0.70 mL; p < 0.001). For the subjects between 2 and 36 months of age, the mean volume was 1.0 mL (range, 0.30-2.0 mL). No other significant differences were observed between groups, thyroid lobes, or gender. However, body mass index correlated significantly with total thyroid volume (r = 0.347; p = 0.001). Conclusion: The mean thyroid dimensions were smallest in the < 2 month age group (0.35 ± 0.16 mL). For the subjects between 2 and 36 months of age, a reference value of 0.85 ± 0.42 mL can be used. Our data could guide the diagnostic investigation of thyroid disease, especially congenital hypothyroidism, in childhood.

27 April 2022 in Family Practice
Verified
Journal Article
Closed access
ASAdriana Paula da Silva
Adriana Paula da Silva
AAAna Cláudia Moura Caetano Araujo
Ana Cláudia Moura Caetano Araujo
IMIzabelle Mara Rodrigues Mesquita
Izabelle Mara Rodrigues Mesquita
EFElvi Cristina Rojas Fonseca
Elvi Cristina Rojas Fonseca
JTJanaíne Machado Tomé
Janaíne Machado Tomé
MBMaria de Fátima Borges
Maria de Fátima Borges
Background: It was verified the level of religiosity and spirituality, and symptoms of depression, stress, and anxiety of caregivers of children and adolescents with type 1 diabetes, and its interference in glycaemic control. Methods: Socio-economic and demographic data were collected from caregivers of 59 children and adolescents with type 1 diabetes and obtained dosages of fasting glucose (FG); postprandial glycaemia (PPG); fructosamine (FRUTO); and HbA1c, as well as the glycaemic variability—∆HbA1c. Levels of religiosity were obtained by the DUREL scale; the use of religious/spiritual coping was verified by the SRCOPE-Brief scale. Symptoms of depression, anxiety, and stress were analysed by the DASS-21 scale. The correlations between the variables were analysed by the Pearson coefficient, with significance at 5% level. Results: Inverse correlations were observed between caregivers’ schooling with PPG (r = −0.30; P = 0.002) and FRUTO (r = −0.34; P = 0.008) and between family income and FRUTO (r = −0.37; P = 0.004). Direct, moderate correlations were observed between negative religious/spiritual coping (NSRCOPE) with symptoms of depression (r = 0.588; P < 0.0001), stress (r = 0.500; P < 0.0001), and anxiety (r = 0.551; P < 0.0001). Conclusion: The direct association between NSRCOPE with symptoms of depression, stress, and anxiety was the highlighted item in the present study emphasizing the need for greater attention to the emotional health of informal caregivers of children and adolescents with DM1. It is necessary to reflect on the religious/spiritual support especially for the main caregiver of children and adolescents with DM1.

1 January 2019 in Clinics
Verified
Journal Article
Open access
PDF file
LFLívia Grimaldi Abud Fujita
Lívia Grimaldi Abud Fujita
HPHeloísa Marcelina da Cunha Palhares
Heloísa Marcelina da Cunha Palhares
ASAdriana Paula da Silva
Adriana Paula da Silva
JTJanaíne Machado Tomé
Janaíne Machado Tomé
MBMaria de Fátima Borges
Maria de Fátima Borges
There are no doubts about the clinical benefits of treatment with GnRH analogs for patients diagnosed with central precocious puberty (CPP). However, laboratory monitoring of CPP is still a matter of considerable controversy in the literature. Therefore, the main objective of this study was to evaluate the cut-off values of stimulated LH that determine gonadotrophic suppression. Twenty-four girls, on treatment with leuprorelin acetate (LA) at 3.75 mg IM every 28 days, were studied. The clinical parameters used to indicate clinical effectiveness were regression or maintenance of sexual characteristics according to the Tanner stage, growth velocity reduction, reduction or maintenance of the difference between bone age and chronological age and maintenance or improvement of the final height prediction. For the laboratory effectiveness test, basal estradiol, LH, and FSH levels were collected before and 1 and 2 h after the administration of 3.75 mg LA. Eleven girls showed improvement in all clinical parameters, and their effectiveness tests were compared to those of the other patients to calculate the cut-off values, which were ≤3.64 IU/L (p=0.004*) for LH after 1 h and ≤6.10 IU/L (p<0.001*) for LH after 2 h. The LH response after the LA stimulation test, associated with clinical data and within a context of CPP, constitutes a reliable and feasible resource and can assist in monitoring the effectiveness of treatment.

1 January 2021 in Revista Paulista de Pediatria
Verified
Journal Article
Open access
PDF file
TFTaciana Carla Maia Feibelmann
Taciana Carla Maia Feibelmann
ASAdriana Paula da Silva
Adriana Paula da Silva
JSJuliana Pereira Pontes Santos
Juliana Pereira Pontes Santos
EAEsthefania Garcia de Almeida
Esthefania Garcia de Almeida
HPHeloisa Marcelina da Cunha Palhares
Heloisa Marcelina da Cunha Palhares
MBMaria de Fátima Borges
Maria de Fátima Borges
Objective: To determine the age of puberty onset in boys and collect anthropometric data of participants at different puberty stages. Methods: This is a cross-sectional study that assessed 430 boys in a random sample representing 48,390 students from public and private schools from the city of Uberaba, Southeast Brazil. The inclusion criteria were males, aged between 5 and 18 years, and absence of previous diseases. Participants and their guardians filled a semistructured questionnaire with questions relevant to their and their parents’ puberty. We set the significance at p<0.05 and calculated the 95% confidence intervals. Results: The mean age found in the puberty stage G2 was 11.2±1.8 (95% of participants in stage G2 were 9.2-13.4 years old). Pubarche data showed a mean of age of 11.0±1.6 years (95% of the participants experienced pubarche when they were 8.0-14.0 years old). When compared to the confidence intervals of two classical studies on the subject, our results showed a trend toward earlier pubarche. In addition, the mean age of this event in the children’s parents was of 12.1±1.4 years, which was significantly higher than the age of the children’s pubarche (p<0.001). Conclusions: These results indicate a secular decreasing trend in pubarche age and an earlier puberty onset. Considering these parameters, is important to design public policies aimed at preventing these early events.

19 December 2021 in Revista Família, Ciclos de Vida e Saúde no Contexto Social
Verified
Journal Article
Open access
PDF file
MPMarina Destefano Prezotto
Marina Destefano Prezotto
ASAdriana Paula Da Silva
Adriana Paula Da Silva
EFElvi Cristina Rojas Fonseca
Elvi Cristina Rojas Fonseca
PFPriscila de Melo Franciscon
Priscila de Melo Franciscon
MBMaria de Fátima Borges
Maria de Fátima Borges
Este é um estudo de corte transversal com delineamento descritivo, com dois grupos populacionais, tipo antes e depois, com abordagem quantitativa do tipo analítica com correlação entre variáveis, realizado entre 2018 e 2019, com objetivo de analisar fatores de risco cardiometabólicos, clínicos e laboratoriais associados à síndrome metabólica em mulheres com tireoidite crônica autoimune eutireoideas, na pré e pós-menopausa, acompanhadas em serviço terciário. Participaram 109 mulheres, sendo 56 com Tireoidite Crônica Autoimune em status eutireoideo e 53 sem disfunção tireoidiana. Das 56 mulheres, 25 foram incluídas no grupo com Tireoidite Crônica Autoimune na pré-menopausa e 31 foram incluídas na pós-menopausa e, das 53 mulheres com função tireoidiana normal, 25 foram incluídas no grupo comparativo na pré-menopausa e 28 no grupo comparativo na pós-menopausa. O perfil metabólico sugeriu resistência insulínica, com taxas mais elevadas no grupo com tireoidite pré e pós-menopausa e grupo controle pós, bem como perfil lipídico desfavorável. Apresentaram síndrome metabólica 36% do grupo afetado pré-menopausa e 51,6% do grupo afetado pós, contra nenhuma e 14,3% dos grupos comparativos, respectivamente. Se resistência insulínica ou obesidade decorreram da tireoidite, o estudo não permitiu concluir. Pacientes com tireoidite devem receber atenção com relação ao perfil lipídico.